Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment. (4th November 2015) - Horton, Brendan; Williams, Jason B; Spranger, Stefani; Gajewski, Thomas F